Related references
Note: Only part of the references are listed.CGRP receptor antagonist activity of olcegepant depends on the signalling pathway measured
Christopher S. Walker et al.
CEPHALALGIA (2018)
Migraine biomarkers in cerebrospinal fluid: A systematic review and meta-analysis
Robin M. van Dongen et al.
CEPHALALGIA (2017)
Calcitonin gene-related peptide induced migraine attacks in patients with and without familial aggregation of migraine
Song Guo et al.
CEPHALALGIA (2017)
Localization of CGRP receptor components and receptor binding sites in rhesus monkey brainstem: A detailed study using in situ hybridization, immunofluorescence, and autoradiography
Sajedeh Eftekhari et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2016)
Mapping the calcitonin receptor in human brain stem
Rebekah L. Bower et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2016)
Bench to bedside advances in the 21st century for primary headache disorders: migraine treatments for migraine patients
Peter J. Goadsby
BRAIN (2016)
Diverse Physiological Roles of Calcitonin Gene-Related Peptide in Migraine Pathology: Modulation of Neuronal-Glial-Immune Cells to Promote Peripheral and Central Sensitization
Paul L. Durham
CURRENT PAIN AND HEADACHE REPORTS (2016)
Type II Turn of Receptor-bound Salmon Calcitonin Revealed by X-ray Crystallography
Eva Johansson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Calcitonin and amylin receptor peptide interaction mechanisms. INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS (vol 291, pg 8686, 2016)
Sang-Min Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
Hong Sun et al.
LANCET NEUROLOGY (2016)
Premonitory and nonheadache symptoms induced by CGRP and PACAP38 in patients with migraine
Song Guo et al.
PAIN (2016)
Wiping Out CGRP: Potential Cardiovascular Risks
Antoinette MaassenVanDenBrink et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Reply to comment on: A second trigeminal CGRP receptor: function and expression of the AMY1 receptor
Christopher S. Walker et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacology
Joseph J. Gingell et al.
CELL DISCOVERY (2016)
Pharmacologic Characterization of AMG 334, a Potent and Selective Human Monoclonal Antibody against the Calcitonin Gene-Related Peptide Receptor
Licheng Shi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Calcitonin Gene-Related Peptide (CGRP): A New Target for Migraine
Andrew F. Russo
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier
Sajedeh Eftekhari et al.
BRAIN RESEARCH (2015)
CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment
Lars Edvinsson
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Targeting CGRP: A New Era for Migraine Treatment
Stephanie Wrobel Goldberg et al.
CNS DRUGS (2015)
Calcitonin gene-related peptide and migraine
Nazia Karsan et al.
CURRENT OPINION IN NEUROLOGY (2015)
The Journey to Establish CGRP as a Migraine Target: A Retrospective View
Lars Edvinsson
HEADACHE (2015)
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
Marcelo E. Bigal et al.
LANCET NEUROLOGY (2015)
Structural Basis for Receptor Activity-Modifying Protein-Dependent Selective Peptide Recognition by a G Protein-Coupled Receptor
Jason M. Booe et al.
MOLECULAR CELL (2015)
A second trigeminal CGRP receptor: function and expression of the AMY1 receptor
Christopher S. Walker et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Amylin: Pharmacology, Physiology, and Clinical Potential
Debbie L. Hay et al.
PHARMACOLOGICAL REVIEWS (2015)
Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program
Marcelo E. Bigal et al.
CEPHALALGIA (2014)
Monoclonal Antibodies for Migraine: Preventing Calcitonin Gene-Related Peptide Activity
Marcelo E. Bigal et al.
CNS DRUGS (2014)
Calcitonin Gene-Related Peptide Receptor Antagonists: New Therapeutic Agents for Migraine
Ian M. Bell
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
David W. Dodick et al.
LANCET NEUROLOGY (2014)
CALCITONIN GENE-RELATED PEPTIDE: PHYSIOLOGY AND PATHOPHYSIOLOGY
F. A. Russell et al.
PHYSIOLOGICAL REVIEWS (2014)
Receptor activity-modifying protein-dependent impairment of calcitonin receptor splice variant Δ(1-47)hCT(a) function
T. Qi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
CGRP in the trigeminovascular system: a role for CGRP, adrenomedullin and amylin receptors?
C. S. Walker et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Localization of CGRP Receptor Components, CGRP, and Receptor Binding Sites in Human and Rhesus Cerebellar Cortex
Sajedeh Eftekhari et al.
CEREBELLUM (2013)
Calcitonin Gene-Related Peptide (CGRP) and Migraine Current Understanding and State of Development
Marcelo E. Bigal et al.
HEADACHE (2013)
Differentiation of Nerve Fibers Storing CGRP and CGRP Receptors in the Peripheral Trigeminovascular System
Sajedeh Eftekhari et al.
JOURNAL OF PAIN (2013)
In Vivo Quantification of Calcitonin Gene-Related Peptide Receptor Occupancy by Telcagepant in Rhesus Monkey and Human Brain Using the Positron Emission Tomography Tracer [11C]MK-4232
Eric D. Hostetler et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Consequences of splice variation on Secretin family G protein-coupled receptor function
Sebastian G. B. Furness et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Pharmacological characterization of rat amylin receptors: implications for the identification of amylin receptor subtypes
R. J. Bailey et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Targeting a family B GPCR/RAMP receptor complex: CGRP receptor antagonists and migraine
Eric L. Moore et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Neuropeptide deficient mice have attenuated nociceptive, vascular, and inflammatory changes in a tibia fracture model of complex regional pain syndrome
Tian-Zhi Guo et al.
MOLECULAR PAIN (2012)
Calcitonin gene-related peptide (CGRP) and its receptor components in human and rat spinal trigeminal nucleus and spinal cord at C1-level
Sajedeh Eftekhari et al.
BMC NEUROSCIENCE (2011)
BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study
Hans-Christoph Diener et al.
CEPHALALGIA (2011)
Neuronal Receptor Activity-Modifying Protein 1 Promotes Energy Expenditure in Mice
Zhongming Zhang et al.
DIABETES (2011)
Long-Term Tolerability of Telcagepant for Acute Treatment of Migraine in a Randomized Trial
Kathryn M. Connor et al.
HEADACHE (2011)
Cerebellar distribution of calcitonin gene-related peptide (CGRP) and its receptor components calcitonin receptor-like receptor (CLR) and receptor activity modifying protein 1 (RAMP1) in rat
Lars Edvinsson et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2011)
Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries
Lars Edvinsson et al.
CEPHALALGIA (2010)
Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura
Jakob Moller Hansen et al.
CEPHALALGIA (2010)
Mice Lacking the Neuropeptide α-Calcitonin Gene-Related Peptide Are Protected Against Diet-Induced Obesity
Christopher S. Walker et al.
ENDOCRINOLOGY (2010)
Pharmacological Properties of MK-3207, a Potent and Orally Active Calcitonin Gene-Related Peptide Receptor Antagonist
Christopher A. Salvatore et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
DIFFERENTIAL DISTRIBUTION OF CALCITONIN GENE-RELATED PEPTIDE AND ITS RECEPTOR COMPONENTS IN THE HUMAN TRIGEMINAL GANGLION
S. Eftekhari et al.
NEUROSCIENCE (2010)
Plasma calcitonin gene-related peptide in diagnosing and predicting paediatric migraine
P-C Fan et al.
CEPHALALGIA (2009)
Role of Calcitonin Gene-Related Peptide in Light-Aversive Behavior: Implications for Migraine
Ana Recober et al.
JOURNAL OF NEUROSCIENCE (2009)
Genetic Enhancement of Calcitonin Gene-Related Peptide-Induced Central Sensitization to Mechanical Stimuli in Mice
Blanca Marquez de Prado et al.
JOURNAL OF PAIN (2009)
The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs
Carlos M. Villalon et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactlivity in the rat trigeminovascular system:: Differences between peripheral and central CGRP receptor distribution
Jochen K. Lennerz et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2008)
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial
Tony W. Ho et al.
LANCET (2008)
International Union of Pharmacology. LXIX. Status of the calcitonin gene-related peptide subtype 2 receptor
Debbie L. Hay et al.
PHARMACOLOGICAL REVIEWS (2008)
Pharmacological characterization of MK-0974 [N-[(3R, 6S)-6(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b] pyridin-1-yl)piperidine-1-carboxamide], a potent and orally Active calcitonin gene-related peptide receptor antagonist for the treatment of migraine
Christopher A. Salvatore et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
CGRP antagonists: unravelling the role of CGRP in migraine
Henri Doods et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
What makes a CGRP2 receptor?
D. L. Hay
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2007)
Post-endocytic sorting of calcitonin receptor-like receptor and receptor activity-modifying protein 1
Graeme S. Cottrell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion
Zhongming Zhang et al.
JOURNAL OF NEUROSCIENCE (2007)
Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4(4-pyridinyl)-l-piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl) (BIBN4096BS) affinity for calcitonin gene-related peptide and amylin receptors -: The role of receptor activity modifying protein 1
Debbie L. Hay et al.
MOLECULAR PHARMACOLOGY (2006)
Pharmacology of the human CGRP1 receptor in Cos 7 cells
Richard J. Bailey et al.
PEPTIDES (2006)
Hydrops fetalis, cardiovascular defects, and embryonic lethality in mice lacking the Calcitonin receptor-like receptor gene
RT Dackor et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes
K Balabanian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Localization of calcitonin receptor-like receptor and receptor activity modifying protein 1 in enteric neurons, dorsal root ganglia, and the spinal cord of the rat
GS Cottrell et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2005)
The Δe13 isoform of the calcitonin receptor forms a six-transmembrane domain receptor with dominant-negative effects on receptor surface expression and signaling
T Seck et al.
MOLECULAR ENDOCRINOLOGY (2005)
Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes
DL Hay et al.
MOLECULAR PHARMACOLOGY (2005)
Safety, tolerability and pharmacokinetics of BIBN4096BS, the first selective small molecule calcitonin gene-related peptide receptor antagonist, following single intravenous administration in healthy volunteers
M Iovino et al.
CEPHALALGIA (2004)
Characterization of the human calcitonin gene-related peptide receptor subtypes associated with receptor activity-modifying proteins
K Kuwasako et al.
MOLECULAR PHARMACOLOGY (2004)
CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors:: a comparison of effects of adrenomedullin22-52, CGRP8-37 and BIBN4096BS
DL Hay et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors
DR Poyner et al.
PHARMACOLOGICAL REVIEWS (2002)
Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature
KR Oliver et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2002)
Agonist-promoted internalization of a ternary complex between calcitonin receptor-like receptor, receptor activity-modifying protein 1 (RAMP1), and β-arrestin
S Hilaire et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Cloning, characterization and distribution of receptor activity central nervous system modifying proteins in the rat
KR Oliver et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
Visualization of the calcitonin receptor-like receptor and its receptor activity-modifying proteins during internalization and recycling
K Kuwasako et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
CGRP and adrenomedullin binding correlates with transcript levels for Calcitonin Receptor-Like Receptor (CRLR) and Receptor Activity Modifying Proteins (RAMPs) in rat tissues
P Chakravarty et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Share Paper
